Novel HIV-1 integrase inhibitors derived from quinolone antibiotics.
about
Retroviral intasome assembly and inhibition of DNA strand transferBroad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137)Computational methods in drug discoveryNovel therapeutic strategies targeting HIV integraseFunctional and structural characterization of the integrase from the prototype foamy virusMolecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance.Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572)A Crystal Structure of the Catalytic Core Domain of an Avian Sarcoma and Leukemia Virus Integrase Suggests an Alternate Dimeric AssemblyApproved Antiviral Drugs over the Past 50 YearsA historical sketch of the discovery and development of HIV-1 integrase inhibitorsEvidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndromeUnprocessed viral DNA could be the primary target of the HIV-1 integrase inhibitor raltegravirResistance mutations outside the integrase coding region have an effect on human immunodeficiency virus replicative fitness but do not affect its susceptibility to integrase strand transfer inhibitorsContribution of human immunodeficiency virus type 1 minority variants to reduced drug susceptibility in patients on an integrase strand transfer inhibitor-based therapyRetroviral DNA IntegrationIn-Silico docking of HIV-1 integrase inhibitors reveals a novel drug type acting on an enzyme/DNA reaction intermediate.Screening for antiviral inhibitors of the HIV integrase-LEDGF/p75 interaction using the AlphaScreen luminescent proximity assay.Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS.HIV-1 IN inhibitors: 2010 update and perspectivesMechanisms and inhibition of HIV integrationBiochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravirPharmacokinetics and dose-range finding toxicity of a novel anti-HIV active integrase inhibitor.New first and second generation inhibitors of human immunodeficiency virus-1 integrase.Development of the next generation of HIV-1 integrase inhibitors: pyrazolone as a novel inhibitor scaffold.Physical trapping of HIV-1 synaptic complex by different structural classes of integrase strand transfer inhibitors.Retroviral Integrase Structure and DNA Recombination MechanismNovel 3'-Processing Integrase Activity Assay by Real-Time PCR for Screening and Identification of HIV-1 Integrase Inhibitors.A novel diketo phosphonic acid that exhibits specific, strand-transfer inhibition of HIV integrase and anti-HIV activity.Characterization of a replication-competent, integrase-defective human immunodeficiency virus (HIV)/simian virus 40 chimera as a powerful tool for the discovery and validation of HIV integrase inhibitors.HIV-1 antiretroviral drug therapy.Synthesis and HIV-1 integrase inhibitory activity of spiroundecane(ene) derivativesClinical Use of Inhibitors of HIV-1 Integration: Problems and Prospects.Computer tools in the discovery of HIV-1 integrase inhibitorsAuthentic HIV-1 integrase inhibitors.Design, Synthesis, and Biological Evaluation of 1,2-Dihydroisoquinolines as HIV-1 Integrase Inhibitors.Tautomerism and magnesium chelation of HIV-1 integrase inhibitors: a theoretical study.One-pot phosphine-catalyzed syntheses of quinolinesMadurahydroxylactone derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and RNase H.Raltegravir: molecular basis of its mechanism of actionMutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro.
P2860
Q24629737-AABD4DAE-FDFE-4623-976E-FD834CCC9B21Q24656978-4535C5DB-B3A0-4FDD-8534-9B879CD5064AQ26997089-D3863A91-9392-4E04-A7EE-3BF53F78F6C1Q27003960-00AA4519-42AD-4E4F-B1F0-22C6BE238E3EQ27653000-7583EF8A-85A9-4DB8-B0B1-531066F6F842Q27665427-6F18AB68-7C0B-4063-8D01-0C92891D8A22Q27670616-F1F8A1FC-77F6-458F-AE40-300D8F3B7D57Q27671859-537D7575-F7D9-4AA0-A492-10E749F2412FQ27755387-B74765AB-2AB4-47A1-BAA5-059EEE7B7B58Q28274166-938264CC-AE13-4E5E-9556-9D46A8A04755Q28304673-B4767E73-DAC4-4906-8DE2-5FA79CEE83CFQ28480958-30E68073-0CC7-4D4B-AB37-874DF4ACFCBDQ28533830-A489046D-39F5-4873-99D4-53A8047A927DQ28541754-88352F72-1160-4015-8FE3-A012EE174722Q28596842-C35681C3-E26F-45EC-8771-BE19D8684B5BQ30479242-680D53F2-F351-498F-B24B-393D3B6BCB63Q33334795-682BE1E1-752F-4C8D-A2E1-DED1C12C63BCQ33680234-BDDFA862-9CCA-441A-8C27-146A630DF217Q33814351-66B2CE7E-1384-4D8E-95C3-DB564F5D2681Q33814406-F6C172F0-2D77-4FB0-BAA0-A053DDC4ECC9Q33838063-A7D82948-158F-44FD-89D1-C47BAC7E881BQ33911400-25D2099A-F5BB-48D5-B4B2-0C036567C0CAQ34186375-59B3D14B-8FF7-4027-91BE-B582A2E3DC39Q34213519-9EAAEEBC-F60F-46EC-9CE3-13932E43A0D8Q34245624-F4027866-AF7D-46F6-86EA-1BBAC4ABA071Q34668065-276553E9-5B91-41C0-BECB-F11B05264A7FQ35630516-B3A0DA7E-25BC-4CB5-B7EB-399EA056BDE2Q35728785-B9C4FA3B-F34A-4FAA-9B69-9C86549AC003Q35785323-98D7B0E6-F560-445C-809F-A7E4E6A57DCEQ35853012-C7FFE8F0-EB85-40E9-91BD-9ECD6D151304Q35855680-82C4C159-7E91-485C-9453-765349C2FB6CQ35944477-123341FC-560E-4407-BE48-58E69D2B585BQ36145611-F83C7C91-280E-4D6B-93A4-D6724979272CQ36145625-23B47E90-8421-462A-85BA-E8518DC2F1FAQ36146699-E6CF9BB2-6B58-4FCB-86B8-C601D484D5CDQ36249020-205697BD-B5C6-4EF8-8865-365445467896Q36283901-0CEF64BE-7F0D-463D-AF3B-0EA6EAD7B535Q36422670-ECFE8164-5C2B-46A3-9FF8-5B780C2F56B1Q36452171-926F0F05-EA9E-42A6-B42B-A3E617534BD4Q36538644-A269CF80-2A73-49F0-AC42-297F2D5F5EB4
P2860
Novel HIV-1 integrase inhibitors derived from quinolone antibiotics.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Novel HIV-1 integrase inhibitors derived from quinolone antibiotics.
@en
type
label
Novel HIV-1 integrase inhibitors derived from quinolone antibiotics.
@en
prefLabel
Novel HIV-1 integrase inhibitors derived from quinolone antibiotics.
@en
P2093
P356
P1476
Novel HIV-1 integrase inhibitors derived from quinolone antibiotics.
@en
P2093
Hiroshi Kawakami
Hisashi Shinkai
Hisateru Aramaki
Kazunobu Yamataka
Masaki Yamashita
Motohide Sato
Satoru Ikeda
Takahisa Motomura
Takashi Matsuda
Wataru Watanabe
P304
P356
10.1021/JM0600139
P407
P577
2006-03-01T00:00:00Z